Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

950 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 417
Recruiting: 234
Ph III recruiting: 22
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (168)

clinicaltrialsPublishedShowing 201–250 of 950 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07261631	Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors	recruiting	Phase 1	180	Novartis PharmaceuticalsINDUSTRY	6	Jun 17, 2026	clinicaltrials
NCT07646106	THE-0504 in Patients With Solid Tumors	recruiting	Phase 1	30	Thena Biotech S.r.l.INDUSTRY	1	Jun 12, 2026	clinicaltrials
NCT05076760